Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | SHBG | P04278 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29458957 | 1.00 | — | — | |
| SCHEMBL40576 | 1.00 | — | — | |
| Ethane SCHEMBL27859312 | 0.97 | TAAR1 (0.52) | TAAR1TSHRACHEPTGS1PTGS2 | |
| SCHEMBL31498537 | 0.97 | TAAR1 (0.52) | TAAR1TSHRACHEPTGS1PTGS2 | |
| Methane SCHEMBL28281016 | 0.97 | TAAR1 (0.52) | TAAR1TSHRACHEPTGS1PTGS2 | |
| Ammonia Solution, Strong SCHEMBL5005672 | 0.97 | TAAR1 (0.52) | TAAR1TSHRACHEPTGS1PTGS2 | |
| SCHEMBL5157331 | 0.97 | TAAR1 (0.52) | TAAR1TSHRACHEPTGS1PTGS2 | |
| O-Xylene SCHEMBL9356149 | 0.97 | TSHR (0.56) | TAAR1TSHRACHEPTGS1PTGS2 | |
| Ammonia Solution, Strong SCHEMBL9453011 | 0.97 | TAAR1 (0.52) | TAAR1TSHRACHEPTGS1PTGS2 | |
| Hydrogen Sulfide SCHEMBL28235130 | 0.97 | TAAR1 (0.52) | TAAR1TSHRACHEPTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103934018-A | Heavy aromatics processing catalyst and process of using the same | EXXONMOBIL CHEM PATENTS INC | 2014-07-23 | — | — | CN | disclosed |
| CN-101842336-B | Heavy aromatics processing catalyst and method of use | EXXONMOBIL CHEM PATENTS INC | 2014-05-07 | — | — | CN | disclosed |
| US-20120202766-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET, INC. (US) | 2012-08-09 | — | — | US | disclosed |
| CN-101842336-A | Heavy aromatics processing catalyst and method of use | EXXONMOBIL CHEM PATENTS INC | 2010-09-22 | — | — | CN | disclosed |
| US-20070078080-A1 | N4-Acylcytosine Nucleosides for Treatment of Viral Infections | GILEAD PHARMASSET LLC | 2007-04-05 | — | — | US | disclosed |
| CN-1043421-C | Process for preparing p-methyl ethyl benzene by reaction of dilute ethylene and toluene | NO 2 PETROLEUM PLANT FUSHUN PE (CN) | 1999-05-19 | — | — | CN | disclosed |
| US-4117024-A | REACTING TOLUENE OR ETHYLBENZENE WITH ETHYLENE, ZEOLITE CATALYST | MOBIL OIL CORPORATION (US) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078080-A1 | N4-Acylcytosine Nucleosides for Treatment of Viral Infections | ENTPD5, DUT, NT5C3B | TAAR1 3913/4885TSHR 4176/4885ACHE 4224/4885 |
| US-20120202766-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | ENTPD5, DUT, NT5C3B | TAAR1 3855/4885TSHR 4165/4885ACHE 4159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.